Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
Chun-Wei LuJong-Hwei Su PangYu-Shien KoChih-Jung ChangChuang-Wei WangWen-Hung ChungChun-Bing ChenRosaline Chung-Yee HuiShuen-Iu HungLai-Ying LuKun Lin LuChih-Liang WangChiao-En WuPing-Chih HsuYueh-Fu FangShih-Hong LiHow-Wen KoLi-Chuan TsengFeng-Ya ShihMei-Jun ChenWen-Hung ChungPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Skin impairment following EGFR-TKI therapy could be ameliorated through zinc supplementation. Thus, zinc supplementation should be considered for cancer patients undergoing EGFR-TKI therapy.